山外山收盘上涨6.68%，滚动市盈率51.97倍，总市值38.49亿元

Company Overview - Chongqing Shanwaishan Blood Purification Technology Co., Ltd. specializes in the research, production, and sales of blood purification equipment and consumables, as well as providing chain dialysis medical services [2] - The main products include blood purification devices and consumables, primarily used for treating acute and chronic renal failure, uremia, multi-organ failure, and poisoning [2] - The company has received multiple national and departmental awards, including the National Information Industry Major Technological Invention Award and has been recognized as a national-level innovative enterprise [2] Financial Performance - As of the latest Q3 2024 report, the company achieved a revenue of 418 million yuan, representing a year-on-year decrease of 27.39% [2] - The net profit for the same period was 61.94 million yuan, down 65.89% year-on-year, with a sales gross margin of 47.54% [2] Market Position - The company's stock closed at 11.98 yuan, up 6.68%, with a rolling price-to-earnings (PE) ratio of 51.97, marking a new low in 66 days [1] - The average PE ratio in the medical device industry is 46.46, with a median of 33.07, placing Shanwaishan at the 91st position in the industry ranking [1][3] - A total of 85 institutions hold shares in Shanwaishan, with a combined holding of 21.34 million shares valued at 238 million yuan [1]